Compassionate use access to investigational medicines: a pioneering industry-academia parternship model

When: Thursday, 1 December 2016 from 16:30 to 19:00

Where: Richard Doll Lecture Theatre, Richard Doll Building, Old Road Campus, Headington, Roosevelt Drive, OX3 7LF Oxford, United Kingdom

This event is open to all, but registration is required. To register click here:

The ethical dilemmas of compassionate use of investigational drugs are under fresh scrutiny by patients and other stakeholders. Legal permission to apply for access to trial medicines does not provide for just process: access routes tend to favour those with resources or privileged contacts with decision-makers. In 2015, Johnson & Johnson (J&J) and New York University Langone Medical Centre partnered to pioneer a compassionate use model that prioritises justice and fair decision-making: The Compassionate Use Advisory Committee (CompAC). In its first year, the CompAC reviewed compassionate use applications from around the world for an experimental drug treatment for multiple myeloma. Companies, patient advocates, IRBs and policymakers have expressed interest in extending the CompAC model into other settings and agents. Dr Amrit Ray, Chief Medical Officer of pharmaceuticals at J&J and Prof Arthur Caplan, NYU Professor of Bioethics tell the story of why CompAC was formed and how it works. They will provide a frank evaluation of its outcomes and challenges and forecast the future implications of the model for IRBs, industry, academia and health policy. Respondents will provide perspectives on the CompAC model from the UK patient/carer community and from health law and policy.



Professor Chas Bountra: Professor of Translational Medicine in the Nuffield Department of Clinical Medicine; Head of Structural Genomics Consortium, University of Oxford


Dr Amrit Ray: Chief Medical Officer, Janssen Pharmaceuticals Companies of Johnson & Johnson

Professor Arthur Caplan: Drs William F and Virginia Connolly Mitty Professor of Bioethics; Langone Medical Centre, New York University


Deborah Binner: Journalist and Patient/Carer Advocate

Daniel Greenberg: Parliamentary Counsel (TBC)


Professor Ilina Singh: Professor of Neuroscience and Society, University of Oxford

This entry was posted in Bioethics and tagged , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s